Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors
A cell-based screening system for viral protease inhibitors was developed using firefly luciferase fragment complementation and validated on the SARS-CoV-2 3CLpro model. The optimal luciferase variant incorporating the VLQSGF proteolytic site (Luc III) retained 88% of its native activity. A critical...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2026-04-01
|
| Col·lecció: | Biosensors |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2079-6374/16/5/253 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|